A large simple placebo controlled trial, among adults with head injury and impaired consciousness, of the effects of a 48-hour infusion of corticosteroids on death and neurological disability. CRASH was a randomised, controlled, double-blind trial undertaken in 239 hospitals in 49 countries. A total of 10008 adults with head injury and a Glasgow Coma Score (GCS) of 14 or less within 8 hours of injury were randomly allocated 48 hour infusion of corticosteroids (methylprednisolone) or placebo. Primary outcomes were death within 2 weeks of injury or disability at 6 months. Prespecified subgroup analyses were based on injury severity (GCS) at randomisation and on time from injury to randomisation and analysis was by intention to treat. Access t...
Abstract Background Worldwide, over 10 million people are killed or hospitalized because of traumati...
Background: Worldwide, traumatic brain injury (TBI) kills or hospitalises over 10 million people eac...
BACKGROUND: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the r...
A large simple placebo controlled trial, among adults with head injury and impaired consciousness, o...
Abstract Background Worldwide, millions of people are treated each year for significant head injury....
BACKGROUND: Worldwide, millions of people are treated each year for significant head injury. A subst...
A large randomised placebo controlled trial among trauma patients with or at risk of significant hae...
MRC CRASH is a randomised controlled trial (ISRCTN74459797) of the effect of corticosteroids on deat...
MRC CRASH is a randomised controlled trial (ISRCTN74459797) of the effect of corticosteroids on deat...
OBJECTIVES: To test the design and feasibility of a large scale multicentre randomised controlled tr...
CRASH (Corticosteroid randomisation after significant head injury) is a prospective multi-centre ran...
The global epidemic of head injuries is just beginning. Many are caused by road traffic crashes. It ...
BACKGROUND: Corticosteroids have been used to treat head injuries for more than 30 years. In 1997, f...
Methylprednisolone was associated with an increase in death after head injury CRASH Trial Collaborat...
BACKGROUND: Worldwide, over 10 million people are killed or hospitalized because of traumatic brain ...
Abstract Background Worldwide, over 10 million people are killed or hospitalized because of traumati...
Background: Worldwide, traumatic brain injury (TBI) kills or hospitalises over 10 million people eac...
BACKGROUND: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the r...
A large simple placebo controlled trial, among adults with head injury and impaired consciousness, o...
Abstract Background Worldwide, millions of people are treated each year for significant head injury....
BACKGROUND: Worldwide, millions of people are treated each year for significant head injury. A subst...
A large randomised placebo controlled trial among trauma patients with or at risk of significant hae...
MRC CRASH is a randomised controlled trial (ISRCTN74459797) of the effect of corticosteroids on deat...
MRC CRASH is a randomised controlled trial (ISRCTN74459797) of the effect of corticosteroids on deat...
OBJECTIVES: To test the design and feasibility of a large scale multicentre randomised controlled tr...
CRASH (Corticosteroid randomisation after significant head injury) is a prospective multi-centre ran...
The global epidemic of head injuries is just beginning. Many are caused by road traffic crashes. It ...
BACKGROUND: Corticosteroids have been used to treat head injuries for more than 30 years. In 1997, f...
Methylprednisolone was associated with an increase in death after head injury CRASH Trial Collaborat...
BACKGROUND: Worldwide, over 10 million people are killed or hospitalized because of traumatic brain ...
Abstract Background Worldwide, over 10 million people are killed or hospitalized because of traumati...
Background: Worldwide, traumatic brain injury (TBI) kills or hospitalises over 10 million people eac...
BACKGROUND: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the r...